SOPHARMA AD (the “Company”) hereby informs that from 19 September 2013 up to and including 25 September 2013 the Company bought 14 524 own shares representing 0.011 % of the share capital of the Company, to the total value of 47 714.54  BGN on the Bulgarian Stock Exchange. The average price per share was 3.29 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 234 246, representing 3.97% of the share capital of the Company.

Sopharma AD (the “Company”) hereby notifies all shareholders of the Company, that the Annual General Meeting, convened by the Board of Directors for 20 June 2014 at 11:00 will take place at Sopharma Business Towers, Building B, floor 3, 5 Lachezar Stanchev Str.. The registration begins at 9:30. All shareholders of the company are invited to participate at the General Meeting in person or by proxy.

SOPHARMA AD (the “Company”) hereby informs that from 12 June 2014 up to and including 18 June 2014 the Company bought 11 400 own shares representing 0.009% of the share capital of the Company, to the total value of 48 287.40 BGN on the Bulgarian Stock Exchange, the average price per share was 4.24 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 4 951 552, representing 3.75% of the share capital of the Company.

Sopharma AD (the “Company”) notifies that on 19 June 2014 Sopharma AD, Sofia, UIC 831902088, hereinafter referred to as "receiving company" and Bulgarian Rose – Sevtopolis AD, Kazanluk, UIC 123007916, hereinafter referred to as "transferring company" signed a Contract for transformation through merger in accordance with the requirements of art. 262d and following of the Commercial Act (CA), as a result of which all assets of Bulgarian Rose – Sevtopolis AD shall be transferred to Sopharma AD and the latter shall become its legal successor.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 21 June 2012 up to and including 27 June 2012 the Company bought 15033 own shares representing 0.011% of the share capital of the Company, to the total value of BGN 33722.31 on the Bulgarian Stock Exchange. The average price per share was BGN 2.24.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 7 June 2012 up to and including 13 June 2012 the Company bought 4305 own shares representing 0.0033% of the share capital of the Company, to the total value of BGN 9749,25 on the Bulgarian Stock Exchange. The average price per share was BGN 2.265.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

On 14. June "Sopharma" received the prestigious international award "Business Partner of 2012". The award was given to the CEO Mr. Ognian Donev on a ceremony in Belgrade.

The award has been given sine 2008 by a panel of the academic community in Serbia, headed by Prof. Elias Chyosich, Dean of the Faculty of Technical Sciences in Novi Sad.

The categories in which the nominated companies competed are three: regional business partner, business partner of Serbia and media partner.

We would like to notify that the Annual General Meeting of shareholders of Sopharma AD, held on 19.06.2012 in Sofia, 16 Iliensko shousee, took the following decisions:

The Board of Directors of Sopharma AD (the “Company”) hereby notifies that on 2 July 2014 Sopharma AD submitted for approval the signed merger agreement between Bulgarian Rose – Sevtopolis AD and Sopharma AD and all accompanying documents to the Financial Supervision Commission.

SOPHARMA AD (the “Company”) hereby informs that from 26 June 2014 up to and including 2 July 2014 the Company bought 27 776 own shares representing 0.021% of the share capital of the Company, to the total value of 115 083.07 BGN on the Bulgarian Stock Exchange, the average price per share was 4.14 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 4 999 048, representing 3.79% of the share capital of the Company.